Ocular Surface Disease

Ocular surface changes noted after immune checkpoint inhibitor therapy

A notable proportion of patients undergoing immune checkpoint inhibitor (ICI) therapy experience changes in markers of ocular surface health, indicating a potential side effect of this treatment, according to a study, which showed that with appropriate medical intervention, such as the use of preservative-free artificial tears, cyclosporine, topical corticosteroids, warm...